Results 1 to 10 of about 18,317 (191)

CRISPR-Edited CART With GM-CSF Knockout and Auto Secretion of IL6 and IL1 Blockers in Patients With Hematologic Malignancy [PDF]

open access: yesCell Discovery, 2021
Revolutionary CART therapy still faces the challenge of severe cytokine release syndrome (CRS). While IL6 and IL1 have been demonstrated as essential contributors, GM-CSF is one of the most abundant inflammatory cytokines secreted by CART and has also ...
Yan Yi, Xiaoshan Chai, Yongjing Zhang
exaly   +4 more sources

Anti-Inflammatory Activity of a Demineralized Bone Matrix: An In Vitro Pilot Study

open access: yesApplied Sciences, 2022
Demineralized bone matrix (DBM) is commonly used for the reconstruction of bone defects. Early graft consolidation involves a transient inflammatory process. It is, however, unclear whether DBM can modulate this process.
Layla Panahipour   +5 more
doaj   +2 more sources

NF-α, IL6, IL1-α, IL-10 and TGF-β1 Gene Expression in Iranian Acute Myeloid Leukemia Patients

open access: yesBasic & Clinical Cancer Research, 2023
Acute myeloid leukemia is a heterogeneous clonal disorder of blood-producing cells that are among the most common malignant disorders in adults. The purpose of this study was to examine the gene expression of TNF-α, IL6, IL1-α, IL-10, and TGF-β1 at diagnosis in acute myeloid leukemia.
Ali Ghorbani Ranjbary
exaly   +2 more sources

Combining Ability and Inheritance Nature of Agronomic Traits and Resistance to Pink Stem (Sesamia cretica) and Purple-Lined (Chilo agamemnon) Borers in Maize

open access: yesPlants, 2023
The pink stem borer (PSB), Sesamia cretica (Lepidoptera: Noctuidae) purple-lined borer (PLB), Chilo agamemnon (Lepidoptera: Crambidae) and European corn borer Ostrinia nubilalis, (Lepidoptera: Crambidae) are considered the most devastating insect pests ...
Saad N. AL-Kahtani   +5 more
doaj   +2 more sources

A Analysis of TNF-α, IL6, IL1-α, IL-10 and TGF-β1 Genes Expression in Acute Myeloid Leukemia Patients in Iranian Patients

open access: yesBasic & Clinical Cancer Research, 2023
Acute myeloid leukemia as one of the most common malignant disorders in adults is a heterogeneous clonal disorder of blood producing cells. The aim of this study was to analyze the expression of TNF-α, IL6, IL1-α, IL-10 and TGF-β1 gene in acute myeloid ...
Ali Ghorbani Ranjbary   +1 more
doaj   +1 more source

Wound Age Estimation: Pro-inflammatory Cytokines versus Immuno-histochemistry [PDF]

open access: yesThe Egyptian Journal of Forensic Sciences and Applied Toxicology, 2022
Rationale and background: In forensic medical investigations, it is an important matter to determine whether a wound found on autopsy was inflicted before or after death and, if inflicted ante-mortem, how long before death it was sustained.
Nevein El-Dessouky   +4 more
doaj   +1 more source

Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients with hematologic malignancy

open access: yesCell Discovery, 2021
IL6 is one of the most elevated cytokines during chimeric antigen receptor (CAR) T cell cytokine release syndrome (CRS), and IL6R blockade by Tocilizumab has successfully relieved the most life-threatening aspects of CRS in patients.
Lei Xue   +12 more
doaj   +1 more source

P03-016 - ANTI IL1 refractory CINCA respondes to ANTI IL6 [PDF]

open access: yesPediatric Rheumatology, 2013
CINCA is thought to be mainly due to a dysregulation of IL1 synthesis and many patients respond to IL1 inhibition. The role of other cytokines in CINCA disease pathogenesis is less clear.
Dueckers, G   +4 more
openaire   +1 more source

Tumor-targeting properties of novel immunocytokines based on murine IL1β and IL6 [PDF]

open access: yesProtein Engineering, Design and Selection, 2014
There is an increasing biotechnological interest in 'arming' therapeutic antibodies with bioactive payloads. Many antibody-cytokine fusion proteins (immunocytokines) have been described and some of these biopharmaceuticals have progressed to clinical studies.
Hess Christian, Neri Dario
openaire   +4 more sources

Biologics in COVID-19 So Far: Systematic Review

open access: yesPharmaceuticals, 2022
This systematic review aimed to reevaluate the available evidence of the use of biologics as treatment candidates for the treatment of severe and advanced COVID-19 disease; what are the rationale for their use, which are the most studied, and what kind ...
Milton Arias   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy